There is a strong need for murine
gastric cancer cell line models recapitulating human
gastric cancers. Here, we describe two murine
gastric cancer cell lines designated as NCC-S1 and NCC-S3. They were generated from gastric
adenocarcinomas that formed in a
Villin-cre, Smad4(F/F) , Trp53(F/F) , Cdh1(F/wt) mouse and a Pdx1-cre, Trp53(F/F) , Cdh1(F/F) mouse, respectively. Molecular profiles of both cell lines were very similar to human
gastric cancer. NCC-S1M and NCC-S3M subpopulation clones were isolated from pulmonary
metastasis of heterotopic allografts of NCC-S1 and NCC-S3 cells, respectively. NCC-S1M and NCC-S3M showed enhanced in vivo growth rates and metastatic potentials and exhibited epithelial-to-mesenchymal transition features. NCC-S1M cells developed orthotopic and heterotopic
tumors in immunocompetent mice in predictable manner, and were useful for testing the efficacy of an immunotherapeutic agent, anti-4-1BB antibody. NCC-S1M and NCC-S3M cells demonstrated Wnt/β-
catenin pathway activation, and knockdown of Ctnnb1 reversed the metastatic phenotype of NCC-S1M. These results underscore the role of Wnt/β-
catenin pathway in metastatic phenotype of
gastric cancer. Taken together, our novel metastatic
gastric cancer cell lines are useful resources for
drug development and
metastasis research.